Shuttle pharmaceuticals stock
WebSep 6, 2024 · The Company's common stock began trading on the Nasdaq Capital Market on August 31, ... Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., CEO 240-403-4212 … WebMar 15, 2024 · March 15, 2024 - 9:00 am. ROCKVILLE, Md., March 15, 2024-- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage …
Shuttle pharmaceuticals stock
Did you know?
WebJan 12, 2024 · In addition, the four-year warrant to purchase up to approximately 1.018 million shares of Shuttle Pharmaceuticals' common stock at an exercise price of $2.35 per share, upon exercise, would ... WebShuttle Pharmaceuticals Inc stock price live 1.26, this page displays NASDAQ SHPH stock exchange data. View the SHPH premarket stock price ahead of the market session or …
WebAug 31, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the … WebMar 9, 2024 · Game Changing Potential. Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of patients …
WebShuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and ... WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure …
WebFunding. Shuttle Pharmaceuticals has raised a total of $4.9M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2024 from a Post-IPO Debt round. Shuttle Pharmaceuticals is registered under the ticker NASDAQ:SHPH . Their stock opened with $8.12 in its Aug 31, 2024 IPO.
WebNov 15, 2024 · ROCKVILLE, Md., Nov. 15, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with the filing … simon sinek being a leaderWebFind the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock quote, history, news and other vital information to help you with your stock trading and investing. simon sinek begin with whyWebApr 7, 2024 · The data shows that as of Mar 14, 2024 short interest in Shuttle Pharmaceuticals Holdings Inc. (SHPH) stood at 1.30% of shares outstanding, with shares … simon sinek authentic leadershipWebAug 30, 2024 · ROCKVILLE, Md., Aug. 30, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing side effects, announced today the pricing of its … simon sinek blockbusterWebDec 31, 2024 · Recent Financing On January 11, 2024, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the "Company"), entered into a securities purchase … simon sinek authenticityWebShuttle Pharmaceuticals Holdings, Inc (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focusing on cancer treatments and radiation therapy. Their Sept 2024 IPO ... simon sinek book recommendationsWebAug 30, 2024 · Shuttle Pharmaceutical's common stock is expected to begin trading on the Nasdaq Capital Market on Wednesday, August 31, 2024 under the symbol "SHPH." simon sinek book free download